FOXP3 suppresses HCC cell proliferation and invasion, likely through the TGF-β/Smad2/3 signaling pathway, although the Δ3,4-FOXP3 variant shows reduced tumor-inhibiting effects (64). Here, TGFB1 is linked to hepatocellular carcinoma.